The long time goal of this study is to evaluate the biological role of cytokines in the pathogenesis of human acquired immunodeficiency syndrome (AIDS) and associated neoplasia. During the present funding period, we have shown that interferon (IFN) can inhibit HIV replication at multiple levels. Thereby IFN is able not only to limit de novo infection and virus replication in persistently infected cells but can also block the transactivation of HIV provirus mediated by HSV infection. We have also shown that a cell, which can synthesize high levels of IFN as a response to HIV-1 infection is nonpermissive to HIV-1 infection. In the present proposal, which is an extension of these studies, we want to analyze the molecule mechanism by which IFN affects different types of HIV infection and determine whether the IFN system has the ability to prevent or down modulate the activation of HIV provirus induced by different cytokines. We will focus on the following questions: 1) What are the molecular mechanisms by which IFN inhibits HIV-1 replication in T-cells and macrophages? 2) What are the characteristics of kappaB binding proteins stimulated by inflammatory cytokines in HIV-1 infected cells? 3) What is the molecule mechanism by which kappaB directed transcription is suppressed in IFN producing cells? and 4) What is the molecular nature of the block in inducible expression of IFN alpha genes in HIV infected cells? We believe that our present results, together with the results of the proposed study, will allow us to evaluate in molecular terms, the complex role of the IFN system in HIV infection as well as to clarify some of the pathways by which IFNs and cytokines may interact with each other. This study should also provide a more rational foundation for the use of IFN and cytokine therapy in HIV infection in man. The fact that IFN can inhibit activation of HIV provirus induced by HSV-1 as well as to abort HIV infection, indicates that in vivo IFN may have a much broader spectrum of effects than we anticipated. It also suggest that the present strategies for clinical use of IFN may be reevaluated and IFN applied in much earlier stages of HIV infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37AI026123-04
Application #
3481323
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1988-09-01
Project End
1996-06-30
Budget Start
1991-09-01
Budget End
1992-06-30
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Barnes, Betsy J; Kellum, Merrill J; Field, Ann E et al. (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 22:5721-40
Popik, W; Hesselgesser, J E; Pitha, P M (1998) Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol 72:6406-13
Popik, W; Pitha, P M (1998) Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 Virology 252:210-7
Shirazi, Y; Pitha, P M (1998) Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells. J Hum Virol 1:69-76
Schafer, S L; Hiscott, J; Pitha, P M (1996) Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells. Virology 224:214-23
Kunzi, M S; Pitha, P M (1996) Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication. J Interferon Cytokine Res 16:919-27
Popik, W; Pitha, P M (1996) Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol Cell Biol 16:6532-41
Schafer, S L; Vlach, J; Pitha, P M (1996) Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol 70:6937-46
Megyeri, K; Au, W C; Rosztoczy, I et al. (1995) Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol 15:2207-18
Kunzi, M S; Farzadegan, H; Margolick, J B et al. (1995) Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis 171:822-8

Showing the most recent 10 out of 30 publications